SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2070)1/2/2008 2:27:31 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
ZILA Is also holding above the $1 level & has been up 10% today.

bigcharts.marketwatch.com

Last month it reported that the U.S. Department of Veterans Affairs awarded it a contract to market its oral cancer screening product, ViziLite Plus with TBlue630, to 58 VA dental clinics and 154 Department of Defense dental clinics.

In November it launched ViziLite Plus in Canada at the Toronto Academy of Dentistry Winter Meeting, marking the initial launch of ViziLite Plus outside the U.S.

It seems that ZILA has better chances than SPEX of reaching the $2 level in 2008 <g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2070)6/24/2009 3:03:35 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
SPEX is having a nice spike today. It is up only 98% at present, but was up 164% earlier.<g>

It announced positive preliminary results from a PII of its , Naturlose (D-tagatose), in the treatment of Type 2 diabetes.

finance.yahoo.com

Volume is close to 10x its ADV.

bigcharts.marketwatch.com

With some good news the stock could get to the $3 level or test the resistance at $4

bigcharts.marketwatch.com

Bernard